Purdue Pharma Public Benefit Settlement Comes Under Fire From Creditors, Congress
NEW YORK — A U.S. attorney on Nov. 13 told a New York bankruptcy judge that if opioid maker Purdue Pharma L.P. becomes a public benefit corporation (PBC), the $225 million...To view the full article, register now.
Already a subscriber? Click here to view full article